US Broker Ratings

MeiraGTx Holdings plc (MGTX) Stock Analysis: Exploring a 128.97% Potential Upside in the Biotech Arena

For investors eyeing opportunities in the biotechnology sector, MeiraGTx Holdings plc (NASDAQ: MGTX) presents a compelling case with its significant potential upside and a robust pipeline..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Navigating Challenges with Innovative Medical Solutions

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a player in the healthcare sector’s medical devices industry, is making waves with its innovative solutions for bunion and foot..

Humacyte, Inc. (HUMA): Investor Outlook on a High-Stakes Biotech with 188.90% Potential Upside

As Humacyte, Inc. (NASDAQ: HUMA) continues to trail blaze in the healthcare sector with its pioneering biotechnology, investors are weighing the pros and cons of this..

Abivax SA (ABVX) Stock Analysis: A 27.62% Potential Upside in the Biotechnology Sector

Investors with a keen eye on the healthcare sector may find Abivax SA (ABVX) to be an intriguing opportunity, particularly within the biotechnology industry. Headquartered in..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Through a Challenging Landscape with 69.36% Potential Upside

For investors eyeing opportunities in the healthcare sector, Myriad Genetics, Inc. (NASDAQ: MYGN) presents a complex yet potentially rewarding scenario. This molecular diagnostics and precision medicine..

Precigen, Inc. (PGEN) Stock Analysis: Strong Growth Potential with an 80% Upside

For investors with a keen eye on the biotechnology sector, Precigen, Inc. (PGEN) presents a fascinating opportunity. This U.S.-based biopharmaceutical company is at the forefront of..

OrthoPediatrics Corp. (KIDS) Investor Outlook: A 10.97% Potential Upside with Solid Buy Ratings

OrthoPediatrics Corp. (NASDAQ: KIDS), a prominent player in the medical device industry focused on pediatric orthopedics, is capturing the attention of investors with its promising growth..

Investiva S.A. (IVA) Stock Analysis: Exploring a 219% Potential Upside in Biotech

Inventiva S.A. (IVA), a French biotechnology firm, is carving a niche in the healthcare sector with its innovative focus on developing oral small molecule therapies. The..

Akso Health Group (AHG) Stock Analysis: Navigating Uncertain Waters in Medical Distribution

Akso Health Group (AHG), a player in the healthcare sector, operates within the medical distribution industry, boasting a market cap of $1.13 billion. Based in Qingdao,..

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: A Biotech Stock with 76% Potential Upside

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a promising player in the biotechnology sector, is capturing the attention of investors with its strong pipeline of innovative therapies and..

AngioDynamics, Inc. (ANGO) Stock Analysis: Uncovering a 32% Potential Upside with Robust Buy Ratings

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector focusing on medical instruments and supplies, presents an intriguing opportunity for investors seeking growth in..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Exploring a 27.94% Potential Upside in the Biotech Sector

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is making waves in the biotechnology sector with its focus on developing innovative treatments for central nervous system (CNS) disorders. With..

Praxis Precision Medicines, Inc (PRAX): Investor Outlook on a Biotech Powerhouse with 71.91% Upside Potential

Praxis Precision Medicines, Inc (NASDAQ: PRAX) is capturing the attention of investors with its strategic focus on developing breakthrough therapies for central nervous system (CNS) disorders...

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: A Biotech Star with 50% Potential Upside

Oruka Therapeutics, Inc. (NASDAQ: ORKA), a burgeoning name in the biotechnology sector, has captured the attention of investors with its promising pipeline of monoclonal antibody therapeutics..

STAAR Surgical Company (STAA) Stock Analysis: Unveiling a 24.95% Potential Upside

For investors keen on the healthcare sector, STAAR Surgical Company (NASDAQ: STAA) presents an intriguing opportunity. Specializing in the design and manufacture of phakic implantable lenses,..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Promising 151% Potential Upside

Sana Biotechnology, Inc. (NASDAQ: SANA), a pioneering player in the biotechnology sector, is capturing investor attention with its significant growth potential. Currently valued at approximately $948.97..

AxoGen, Inc. (AXGN) Stock Analysis: A Promising 20% Upside in the Medical Devices Sector

AxoGen, Inc. (NASDAQ: AXGN), a leading player in the healthcare sector specializing in medical devices for peripheral nerve regeneration, is drawing attention from investors with its..

Verastem, Inc. (VSTM) Stock Analysis: 151.69% Potential Upside in Biotech Space

Verastem, Inc. (NASDAQ: VSTM), a promising player in the biotechnology sector, is capturing the attention of investors with its potential for substantial upside. As a development-stage..

Autolus Therapeutics plc (AUTL) Stock Analysis: Biotechnology Innovator with 333% Potential Upside

Autolus Therapeutics plc (NASDAQ: AUTL), a clinical-stage biopharmaceutical company based in London, UK, is capturing investor attention with its innovative approach to T cell therapies for..

Kamada Ltd. (KMDA) Stock Analysis: Unpacking an 82% Potential Upside in the Healthcare Sector

For investors with a keen eye on the healthcare sector, Kamada Ltd. (NASDAQ: KMDA) presents an intriguing opportunity. Specializing in plasma-derived protein therapeutics, this Israeli-based company..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds